
|Articles|January 6, 2005
Combination treatment increases survival in high-risk PCa patients
A combination of brachytherapy and external radiation plus androgen deprivation gives prostate cancer patients with high-risk disease a better chance of survival than patients treated with radiation alone, according to a study in the International Journal of Radiation Oncology*Biology*Physics (2005; 61:32-43).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Study suggests potential diuretic effect with nadofaragene firadenovec
2
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
3
Praful Ravi, MB, BChir, MRCP, on PSMA-PET during initial systemic therapy for mHSPC
4
Published data show DFS benefit with aglatimagene besadenovec in localized prostate cancer
5











